Terms of Service
These Terms of Service ("Terms") govern access to and use of the Triple Helix Science web portal, research platform overviews, institutional inquiry mechanisms, and related scientific information services. By accessing or using our services, institutions, medical professionals, and visitors agree to be bound by these Terms.
1. Informational & Institutional Nature of Services
Triple Helix Science operates translational biotechnology pipelines, preclinical vector platforms, and clinical trial programs. Content published on this website is for scientific, institutional, and research evaluation purposes only and does not constitute individualized medical diagnosis, treatment recommendations, or a guarantee of trial eligibility.
- Patients seeking medical advice must consult directly with licensed medical practitioners.
- Physician referral submissions are subject to protocol-specific clinical review and IRB inclusion criteria.
- Investigational modalities mentioned may not yet be approved by all national regulatory bodies for commercial clinical use.
2. Proprietary Science & Intellectual Property
All scientific content, vector designs, diagrams, patent documentation, clinical methodologies, trademarks, and design systems on this portal are the exclusive intellectual property of Triple Helix Science or its collaborative research partners.
- Unauthorized commercial reproduction, decompilation, reverse engineering, or scraping of scientific data is strictly prohibited.
- The Triple Helix Science name, logo, division identifiers, and brand emblems are protected trademarks.
- Academic citations of public THS whitepapers must include appropriate attribution and copyright notices.
3. Institutional Referral & Consultation Portal Use
Healthcare institutions, hospital departments, and referring clinicians utilizing our secure consultation intake portals agree to provide accurate, authorized documentation in compliance with all relevant medical licensing and patient consent requirements.
- Referring clinicians warrant they possess patient authorization for cross-border case evaluation.
- THS reserves the right to decline or redirect consultations that do not align with active research indications.
4. Limitation of Liability
To the maximum extent permitted by applicable law, Triple Helix Science, its officers, scientific directors, and research affiliates shall not be liable for any indirect, incidental, special, or consequential damages resulting from the use of, or inability to use, our digital platforms or preliminary scientific disclosures.
5. Governing Law & Dispute Resolution
These Terms are governed by and construed in accordance with standard international commercial arbitration principles. Institutional contracts and clinical agreements entered into with sovereign partners shall supersede these general terms in accordance with their executed terms.